RegenMedTX
2014
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
Description
Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
+1 (336) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore RegenMedTX’s full profile, request a free trial.
RegenMedTX Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Mar-2016 | 00.000 | Completed | Startup | ||
| 1. Angel (individual) | 05-Aug-2015 | 00.000 | 00.000 | Completed | Startup |
RegenMedTX Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 06-Mar-2015 | 000000000000000000 | 000.00 | Biotechnology |
RegenMedTX Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Timothy Bertram Ph.D | Chief Executive Officer, Board Member and Managing Director | ||
| Deepak Jain Ph.D | Chief Operating Officer |
RegenMedTX Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Kim Westmoreland | Self | Board Member | 000 0000 | |
| Timothy Bertram Ph.D | RegenMedTX | Chief Executive Officer, Board Member and Managing Director | 000 0000 | |
| William Hawkins III | Self | Chairman | 000 0000 |